期刊文献+

cyclin D1基因沉默对K562细胞化疗增敏作用的体外研究

Effect of silencing cyclin D1 gene on chemotherapeutic drug sensitivity in K562 cells in vitro
原文传递
导出
摘要 目的 cyclin D1基因在细胞周期调控中起关键性作用.研究表明其过表达与肿瘤的发生、发展及预后密切相关;并且与肿瘤细胞对化疗药物的抗拒性有关.抑制cyclin D1蛋白表达可达到化疗增敏作用.研究目的在于利用RNA干扰(RNAi)技术体外观测其对K562细胞cyclin D1基因的沉默效应及其增强多柔比星(ADM)对K562细胞毒性的作用.方法 体外构建靶向cyclin D1基因的小发夹RNA(shRNA)表达质粒,通过壳聚糖介导转染K562细胞,Western Blotting分析检测转染前后cyclin D1蛋白表达变化,流式细胞术检测细胞周期分布及对凋亡率的影响,MTF法检测K562细胞对ADM敏感性的变化.结果 构建了靶向cyclin D1基因的shRNA表达质粒(pshRNA-419和pshRNA-575)经壳聚糖转染后,能显著抑制cyclin D1基因表达;影响K562细胞周期分布,诱导细胞凋亡.并降低ADM半数抑制浓度,提高了化疗敏感性.而设计一碱基突变的序列所构建的质粒并无上述生物学效应.结论 沉默K562细胞cyclin D1基因表达可达到有效的化疗增敏目的. Objective Cyclin D1 gene plays a significant role in regulating cell cycle progression.It is reported that over-expression of cyclin D1 gene is intimately associated with origination,development and prognosis of tumor and is associated with tumor cells resistance to chemotherapy drug.Suppression of cyclin D1 protein expression leads to cellular chemosensitization.This study was to determine whether this effect also existed in chronic leukemia cell line K562 by inhibiting the expression of cyclin D1 protein through RNA interference.Methods Plasmid vectors expressing small hairpin RNA (shRNA) targeting at cyclin D1 gene were constructed and transfected into K562 cells by chitosan.Cyclin D1 protein was examined using Western Blotting analysis.The cell cycle and apoptosis were determined by flow cytometry.Cellular chemosensitization was evaluated by MTY assay. Results Expression of cyclin D1 protein was markedly down-regulated after transfection with pshRNA-419 and pshRNA-575 at 48 h.Down-regulation of cyclin D1 protein could affect the redistribution of cell cycle,induce apoptosis of K562 cells,decrease 50%inhibitoryconcentration (IC50) of adriamycin and enhance cellular chemosensitization.But there had no above biological effects observed after transfection with blank vector and control vector of m-pshRNA-790 at 48 h.Conclusion K562 cells could be chemosensitized by the down-regulation of cyclin D1 expression through RNA interference.
出处 《肿瘤研究与临床》 CAS 2008年第3期148-151,共4页 Cancer Research and Clinic
  • 相关文献

参考文献7

  • 1Jiang W,Kahn SM,Zhou P. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control,cell cycle progression and gene expression[J].Oncogene,1993,(12):3447-3457.
  • 2Kim SH,Lewis JJ,Brennan MF. Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas[J].Clinical Cancer Research,1998,(10):2377-2382.
  • 3Kommann M,Danenberg KD,Arber N. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes[J].Cancer Research,1999,(14):3505-3511.
  • 4Hannon GJ. RNA interference[J].Nature,2002,(6894):244-251.doi:10.1038/418244a.
  • 5Jares P,Rey JM,Fernandes PL. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma:correlation with tumor proliferation and oestrogen receptor status[J].Journal of Pathology,1997,(01):160-167.
  • 6Hojoh H. RNA interference induction with various types of synthetic oligonuleotide duplexes in cultured human cells[J].Federation of European Biochemical Societies Letters(FEBS),2002,(1-3):195-199.
  • 7万一元,张星,何友兼,姜文奇.壳聚糖作为基因治疗载体的可行性研究[J].癌症,2005,24(11):1408-1411. 被引量:7

二级参考文献18

  • 1Choi YH, Liu F, Kim JS, et al.Polyethylene glycol-grafted poly-Llysine as polymeric gene carrier [J]. J Control Release, 1998,54( 1 ): 39-48.
  • 2Walter E, Dreher D, Kok M, et al.Hydrophilic poly (DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells [J]. J Control Release, 2001,76(1-2): 149-168.
  • 3Richardson SC, Kolbe HV, Duncan R. Potential of low molecular mass chitosan as a DNA delivery system:biocompatibility, body distribution and ability to complex and protect DNA [J]. Int J Pharm, 1999,178(2):231-243.
  • 4Borchard G. Chitosans for gene delivery [J]. Adv Drug Deliv Rev, 2001,52(2): 145-150.
  • 5Janes KA, Calvo P, Alonso MJ.Polysaccharide colloidal particles as delivery systems for macromolecules [J]. Adv Drug Deliv Rev, 2001,47( 1 ): 83-97.
  • 6Kas HS. Chitosan: properties,preparations and application to microparticulate systems [J]. J Microencapsul, 1997,14 (6):689-711.
  • 7Lee JY, Nam SH, Im SY, et al.Enhanced bone formation by controlled growth factor delivery from chitosanbased biomaterials [J]. J Control Release, 2002,78(1-3): 187-197.
  • 8Janes KA, Fresneau MP, Marazuela A, et al. Chitosan nanoparticles as delivery systems for doxorubicin [J]. J Control Release, 2001,73(2-3) :255-267.
  • 9Guang Liu W, De Yao K. Chitosan and its derivatives-a promising nonviral vector for gene transfection [J]. J Control Release, 2002,83(1): 1-11.
  • 10Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency [J]. J Control Release, 2001,70 (3) :399-421.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部